Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Financing Activities: 2013-2024

Historic Cash from Financing Activities for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $262.0 million.

  • Surgery Partners' Cash from Financing Activities fell 105205.48% to -$84.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.3 million, marking a year-over-year decrease of 13512.41%. This contributed to the annual value of $262.0 million for FY2024, which is 26881.44% up from last year.
  • Surgery Partners' Cash from Financing Activities amounted to $262.0 million in FY2024, which was up 26881.44% from -$155.2 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Cash from Financing Activities ranged from a high of $316.3 million in FY2021 and a low of -$155.2 million during FY2023
  • Its 5-year average for Cash from Financing Activities is $106.4 million, with a median of $66.7 million in 2020.
  • Per our database at Business Quant, Surgery Partners' Cash from Financing Activities surged by 37421.29% in 2021 and then plummeted by 46864.61% in 2023.
  • Annual analysis of 5 years shows Surgery Partners' Cash from Financing Activities stood at $66.7 million in 2020, then soared by 374.21% to $316.3 million in 2021, then crashed by 86.69% to $42.1 million in 2022, then crashed by 468.65% to -$155.2 million in 2023, then surged by 268.81% to $262.0 million in 2024.
  • Its Cash from Financing Activities stands at $262.0 million for FY2024, versus -$155.2 million for FY2023 and $42.1 million for FY2022.